bioAffinity Technologies (BIAF) Gross Profit (2022 - 2025)

bioAffinity Technologies has disclosed Gross Profit across 4 years of filings, most recently posting $692687.0 for Q4 2025.

• In Q4 2025, Gross Profit rose 7.32% year-over-year to $692687.0; the TTM figure through Dec 2025 stood at $1.9 million (down 42.72% YoY), while the FY2025 annual figure was $1.9 million, down 42.72% from the prior year.
• Gross Profit rose to $692687.0 in Q4 2025, from $503855.0 in the prior quarter.
• Over the last five years, Gross Profit for BIAF reached as high as $989942.0 in Q2 2024 and fell as low as $834.0 in Q1 2023.
• The 4-year median for Gross Profit is $485737.0 (2025), against an average of $407310.5.
• Annual changes were most pronounced in 2024 — Gross Profit jumped 99774.1% — and 2025, when it sank 74.45%.
• A 4-year view of Gross Profit shows it stood at $2171.0 in 2022, then jumped by 25164.72% to $548497.0 in 2023, then rose by 17.67% to $645427.0 in 2024, then gained by 7.32% to $692687.0 in 2025.
• According to Business Quant data, Gross Profit over the past three periods registered $692687.0, $503855.0, and $252881.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.